ACTA2 and liver cancer: In liver cancer cells, ACTA2-AS1 was typically downregulated, and knockdown of this lncRNA significantly promoted the proliferation, cell cycle progression, migration, and invasion of LM3 cells by suppressing E-cadherin and caspase 3 expression and increasing N-cadherin, cyclin D1, and MMP expression [55].